Clinical phenotypes and genetic features of hereditary transthyretin amyloidosis patients in China

被引:9
作者
He, Xinyue [1 ]
Tian, Zhuang [1 ,2 ]
Guan, Hongzhi [3 ]
Zhang, Shuyang [1 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Int Med Serv, Beijing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurol, Beijing, Peoples R China
关键词
Transthyretin amyloidosis; Rare disease; Hereditary; Chinese; VITREOUS AMYLOIDOSIS; POLYNEUROPATHY; MUTATION; GLY83ARG;
D O I
10.1186/s13023-022-02481-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Hereditary transthyretin amyloidosis (hATTR) is a progressive and fatal disease with heterogenous clinical presentations, limited diagnosis and poor prognosis. This retrospective analysis study aimed to report the genotypes and phenotypes of herediary transthyretin amyloidosis (hATTR) in Chinese through a systematic review of published literature. Methods The systematic review included structured searches of peer-reviewed literature published from 2007 to 2020 of following online reference databases: PubMed, Web of Science and the literature database in China. Extracted data included sample size, personal information (sex, age, natural course, family history), mutation type, clinical milestones and reason of death. Results We described 126 Chinese patients with hereditary transthyretin amyloidosis identified through a systematic review of 30 studies. The most common genotype in the Chinese population was Gly83Arg (25, 19.8%), which most likely presented visual and neurological abnormalities without reported death. The second and third most common genotypes were Val30Met (20, 15.9%) and Val30Ala (10, 7.9%). Peripheral neurological manifestations (91, 72%) were dominant in 126 patients. The followed manifestation was autonomic neurological abnormalities (73, 58%). Half of the cases were reported to have visual disorders, and nearly one-third of the cases presented cardiac abnormalities. Among all 126 reported patients, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. In addition. Chinese patients were mostly early onset, with age of onset at 41.8 (SD: 8.9) years, and the median time from onset to death was 7.5 [IQR: 5.3] years. Patients with cardiac involvement had a shorter survival duration (log Rank (Mantel-Cox), chi(2) = 26.885, P < 0.001). Conclusions This study focused on 126 Chinese hATTR patients obtained from a literature review. A total of 26 kinds of TTR mutations were found and the most common one was Gly83Arg. As for phenotype, 46.03% were classified as neurological type, 30.16% as mixed type and only 2.38% as cardiac type. Chinese hATTR patients were mostly early onset (AO 41.8 years), and the median time from onset to death was 7.5 years.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Hereditary Transthyretin Amyloidosis in Eight Chinese Families
    Meng, Ling-Chao
    Lyu, He
    Zhang, Wei
    Liu, Jing
    Wang, Zhao-Xia
    Yuan, Yun
    CHINESE MEDICAL JOURNAL, 2015, 128 (21) : 2902 - 2905
  • [32] Burden of hereditary transthyretin amyloidosis on quality of life
    Yarlas, Aaron
    Gertz, Morie A.
    Dasgupta, Noel R.
    Obici, Laura
    Pollock, Michael
    Ackermann, Elizabeth J.
    Lovley, Andrew
    Kessler, Asia Sikora
    Patel, Pankaj A.
    White, Michelle K.
    Guthrie, Spencer D.
    MUSCLE & NERVE, 2019, 60 (02) : 169 - 175
  • [33] Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population
    Jercan, Andreea
    Ene, Amalia
    Jurcut, Ruxandra
    Draghici, Mirela
    Badelita, Sorina
    Dragomir, Mihaela
    Dobrea, Camelia
    Popescu, Monica
    Jardan, Dumitru
    Stoica, Emanuel
    Iacob, Speranta
    Codita, Ionela
    Stan, Claudiu
    Coriu, Daniel
    ORPHANET JOURNAL OF RARE DISEASES, 2020, 15 (01)
  • [34] Advances in the treatment of hereditary transthyretin amyloidosis: A review
    Gertz, Morie A.
    Mauermann, Michelle L.
    Grogan, Martha
    Coelho, Teresa
    BRAIN AND BEHAVIOR, 2019, 9 (09):
  • [35] Clinical model for Hereditary Transthyretin Amyloidosis age of onset prediction
    Pedroto, Maria
    Coelho, Teresa
    Jorge, Alipio
    Mendes-Moreira, Joao
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [36] Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China
    Wang, Shuai
    Peng, Wenke
    Pang, Min
    Mao, Ling
    Peng, Daoquan
    Yu, Bilian
    Wu, Sha
    Hu, Die
    Yang, Yang
    He, Jia
    Ouyang, Mingqi
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [37] Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy
    He, Shan
    Tian, Zhuang
    Guan, Hongzhi
    Li, Jian
    Fang, Quan
    Zhang, Shuyang
    ORPHANET JOURNAL OF RARE DISEASES, 2019, 14 (01)
  • [38] Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progression
    Conceicao, Isabel
    Coelho, Teresa
    Rapezzi, Claudio
    Parman, Yesim
    Obici, Laura
    Galan, Lucia
    Rousseau, Antoine
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2019, 26 (03): : 103 - 111
  • [39] Hereditary Transthyretin Amyloidosis Neuropathy with Intracellular Amyloidosis and Inclusions
    Lu, Jian-Qiang
    Mak, Gloria
    Grant, Sandra
    Baker, Steven K.
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2024,
  • [40] Abnormal small bowel motility in patients with hereditary transthyretin amyloidosis
    Wixner, J.
    Tornblom, H.
    Karling, P.
    Anan, I.
    Lindberg, G.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 30 (09)